Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
PaperCitations, authors & open-access status
A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 317 citations, 2015 year and gold oa status.
317
Citations
2015
Year
gold
OA Status